Incorporating new evidence on inhaled medications in COPD. The Latin American Chest Association (ALAT) 2019
MM de Oca, MVL Varela, A Acuña, E Schiavi… - Archivos de …, 2020 - Elsevier
… , quality of life, and lung function, and tiotropium bromide in preference to ipratropium in terms
… efficacy of tiotropium and fluticasone/salmeterol in patients with moderate-severe COPD is …
… efficacy of tiotropium and fluticasone/salmeterol in patients with moderate-severe COPD is …
Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score …
S Muro, M Suzuki, S Nakamura, JR Wang… - Respiratory …, 2021 - Springer
… However, it was notable that the magnitude of the effect of tiotropium/olodaterol compared
with tiotropium monotherapy for the risk of first moderate-to-severe COPD exacerbation in this …
with tiotropium monotherapy for the risk of first moderate-to-severe COPD exacerbation in this …
The efficacy and safety of three types of combination therapies in patients with moderate to very severe COPD: a systematic review and meta-analysis.
R Zhou, L Wang, T Sun, Z Wu… - Journal of Chinese …, 2019 - search.ebscohost.com
… of umeclidinium added to fluticasone propionate/salmeterol in patients with COPD: results of
… Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in …
… Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in …
Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian …
… We included 16 RCTs involving a total of 39,065 patients with stable COPD. Six
combinations of LAMA/LABA were identified: tiotropium/salmeterol, glycopyrrolate/indacaterol, …
combinations of LAMA/LABA were identified: tiotropium/salmeterol, glycopyrrolate/indacaterol, …
Treatment efficacy of LAMA versus placebo for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis
Y Suzuki, S Sato, K Sato, S Inoue, Y Shibata - Respiratory Investigation, 2022 - Elsevier
… A systematic review and meta-analysis were conducted to identify randomized and
double-blinded trials of stable COPD patients treated with LAMAs (tiotropium, glycopyrronium, …
double-blinded trials of stable COPD patients treated with LAMAs (tiotropium, glycopyrronium, …
indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study
H Watz, JM Hohlfeld, D Singh, J Beier, Z Diamant… - Respiratory …, 2020 - Springer
… (od) treatment for patients with chronic obstructive pulmonary disease (COPD). Recently, …
function parameters and rescue medication use with IND/GLY/MF compared with salmeterol/…
function parameters and rescue medication use with IND/GLY/MF compared with salmeterol/…
Reduction in all-cause mortality with fluticasone furoate/umeclidinium/vilanterol in patients with chronic obstructive pulmonary disease
DA Lipson, C Crim, GJ Criner, NC Day… - American journal of …, 2020 - atsjournals.org
… The INSPIRE study (6) demonstrated a 52% reduction in the hazard of on-treatment ACM
with salmeterol/fluticasone propionate compared with tiotropium (HR, 0.48 [95% CI, 0.27 to …
with salmeterol/fluticasone propionate compared with tiotropium (HR, 0.48 [95% CI, 0.27 to …
Inhaled therapies for asthma and chronic obstructive pulmonary disease
Y Liang, JCW Mak - Current Pharmaceutical Design, 2021 - ingentaconnect.com
… stable COPD is to prevent acute exacerbation of COPD, to reduce symptoms, and to minimize
the rate of lung function … β2agonists [54], whereas tiotropium is the only long-acting musca…
the rate of lung function … β2agonists [54], whereas tiotropium is the only long-acting musca…
[PDF][PDF] Safety and efficacy of formoterol/tiotropium bromide and formoterol/glycopyrronium combination in patients with chronic obstructive pulmonary disease
JA Siraj Ahmad, F Ahmad, Z Ahmad - International Journal of …, 2023 - academia.edu
… ; salmeterol and formoterol) and LAMA (eg; tiotropium, aclidinium and glycopyrronium bromide)
are the mainstay of treatment of COPD… of stable chronic obstructive pulmonary disease in …
are the mainstay of treatment of COPD… of stable chronic obstructive pulmonary disease in …
Therapeutic success of tiotropium/olodaterol, measured using the clinical COPD questionnaire (CCQ), in routine clinical practice: a multinational non-interventional …
A Valipour, S Avdeev, A Barczyk, V Bayer… - … obstructive pulmonary …, 2021 - Taylor & Francis
… tiotropium/olodaterol, over 80% of the patients we surveyed had better clinical control of COPD,
… Patients in the study also needed less rescue medication (use of short-acting drugs such …
… Patients in the study also needed less rescue medication (use of short-acting drugs such …